Trial intelligence / Profile preview

CRUSADE-1: Bioequivalence of Crushed vs Whole Epclusa Tablets

2016-003941-27Phase 4Completed

Sponsor
Radboud University Medical Center
Start
Oct 2017
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of velpatasvir in chronic hepatitis C (CHC), sponsored by Radboud University Medical Center. Primary endpoint: Bioequivalence of crushed vs whole sofosbuvir/velpatasvir tablets. Started Oct 2017; status: completed.

02

Drugs

velpatasvir
03

Conditions

chronic hepatitis C (CHC)

Beyond the preview

Go deeper on 2016-003941-27.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2016-003941-27.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call